Shares of medical technology company Hologic (NASDAQ:HOLX) jumped 3.1% in the afternoon session after the company announced it agreed to be acquired by private equity firms Blackstone and TPG in a deal that takes the company private.
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Shares of global alternative asset manager TPG (NASDAQ:TPG) jumped 2.3% in the morning session after reports surfaced that the private equity firm, along with Blackstone, was in advanced negotiations to acquire medical device maker Hologic. The potential take-private deal valued Hologic at more than $17 billion, including debt, with a discussed price above $75 per share. According to people familiar with the matter, the firms had agreed on the terms and lined up the necessary debt financing for what would be one of the year's biggest take-private transactions. The news also caused shares of Hologic to rise.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
While the S&P 500 is up 34.7% since April 2025, Hologic (currently trading at $67.73 per share) has lagged behind, posting a return of 15.9%. This might have investors contemplating their next move.
Clairity Inc. is set to transform the landscape of early breast cancer detection with its groundbreaking AI-powered risk prediction technology, Clairity Breast. Having secured De Novo authorization from the U.S. Food and Drug Administration (FDA) in late May 2025, this innovative platform is the first artificial intelligence tool authorized
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics stocks, including Hologic (NASDAQ:HOLX) and its peers.
The healthcare sector stands on the precipice of a monumental transformation, driven by the relentless advance of Artificial Intelligence (AI). From streamlining administrative tasks to enhancing diagnostic accuracy, AI promises a future of more efficient, accessible, and personalized care. However, this technological revolution is not without its complexities, sparking debates
Wall Street kept driving equity valuations higher on Friday, extending the momentum from Thursday when all major U.S. benchmarks closed at record highs following the Federal Reserve's rate cut.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently -
over the past six months, the collective 1.4% gain for healthcare stocks has fallen short of the S&P 500’s 15.5% rise.
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities.
However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Hologic (HOLX) shows strong technicals with an 8 rating and a high-grade bull flag setup rated 9, signaling a potential breakout above $68.77 resistance.
